KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Capital Employed (2016 - 2026)

Medpace Holdings filings provide 11 years of Return on Capital Employed readings, the most recent being 79.56% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 2752.0% to 79.56% in Q1 2026 year-over-year; TTM through Mar 2026 was 79.56%, a 2752.0% increase, with the full-year FY2025 number at 77.03%, up 1932.0% from a year prior.
  • Return on Capital Employed hit 79.56% in Q1 2026 for Medpace Holdings, down from 102.77% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 133.99% in Q3 2025 to a low of 23.32% in Q1 2022.
  • Median Return on Capital Employed over the past 5 years was 52.04% (2025), compared with a mean of 61.36%.
  • Biggest five-year swings in Return on Capital Employed: crashed -1501bps in 2024 and later soared 9143bps in 2025.
  • Medpace Holdings' Return on Capital Employed stood at 51.9% in 2022, then increased by 0bps to 52.09% in 2023, then dropped by -13bps to 45.23% in 2024, then soared by 127bps to 102.77% in 2025, then dropped by -23bps to 79.56% in 2026.
  • The last three reported values for Return on Capital Employed were 79.56% (Q1 2026), 102.77% (Q4 2025), and 133.99% (Q3 2025) per Business Quant data.